MedTrace Logo

The Efficacy Study of Aclasta on Prosthetic Fixation in Postmenopausal Women After THA

NCT02333344 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2019-09-16

No results posted yet for this study

Summary

It's to investigate the efficacy of Zoledronic acid treatment on the early prosthetic fixation in post-menopausal osteoporosis women under cementless total hip arthroplasty after 24-month observation.

Conditions

  • Prosthetic Fixation After Cementless Total Hip Arthroplasty

Interventions

DRUG

Zoledronic acid 5mg

two-year Zoledronic acid 5mg infusion treatment

Sponsors & Collaborators

Principal Investigators

  • Novartis Pharmaceuticals · Novartis Pharmaceuticals

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
55 Years
Max Age
80 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-30
Primary Completion
2020-01-28
Completion
2020-01-28

Countries

  • China

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02333344 on ClinicalTrials.gov